NXL Nexalin Technology Inc: Net earnings per share growth forecast for next year

Official company branding of Nexalin Technology, Inc. (NXL)

Nexalin Technology, Inc. (NXL) utilizes Asian outsourcing for the assembly of neurostimulators to minimize costs and implements unique treatment methods to overcome medical conservatism. The consensus estimate for net profit growth demonstrates fundamental resilience, and this metric has reached the level of 33.90. Management is focused on securing clinical evidence of the efficacy of its non-invasive developments for the therapy of psychiatric disorders.

NXL - Nexalin Technology, Inc. Expected earnings per share trend next year over the range 04/28/2023 - 11/15/2026

Metric breakdowns and analytics for Nexalin Technology Inc (NXL)

- share price and consensus valuation forecast:
Stock Price Nexalin Technology|NXL - Analyst Median Target
- company stock capitalization data:
Market Value NXL|NXL - Business Value
- company book value details:
Accounting Value per Share Nexalin Technology|NXL - Accounting Value of Company|Market Cap to Net Assets Ratio nexalin.com|NXL - Aggregate Business Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Nexalin Technology, Inc.|NXL - Long-Term Liabilities to Capital|Short-Term Debt to Capital nexalin.com|NXL - Company Total Debt|Debts to Book Capitalization Nexalin|NXL - Company Long-Term Loans and Borrowings|Company Short-Term Debt Nexalin Technology|Quick Liquidity nexalin.com
- earnings and market ratios statistics:
NXL - Company Net Income|Expected Profit Nexalin Technology, Inc.|NXL - Price to Earnings Ratio|Future Price to Earnings Nexalin Technology Inc|NXL - Price to Earnings Adjusted for Growth Rate|EV/EBITDA Multiple Nexalin Technology Inc|NXL - Operating profit before depreciation charges|Net earnings per share for the last 12 months Nexalin Technology|NXL - Net earnings per one share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months nexalin.com|NXL - Earnings per share increase in current year|Earnings growth forecast for next year Nexalin Technology, Inc.
- sales and revenue indicators:
NXL - Company Gross Revenue|Company Projected Revenue Nexalin Technology|NXL - Market Cap to Revenue Ratio|Forward P/S Multiple Nexalin|NXL - Revenue Growth YoY (Last 12 Months)
Comprehensive company analysis:Nexalin Technology Inc, NXL
Finished products of Nexalin Technology

Nexalin Technology, Inc. (NXL) is implementing innovative frequency neurostimulation for the non-pharmacological treatment of psychiatric disorders, creating a unique technological barrier. The historical trend of the next year's EPS forecast reflects the analysts' consensus valuation regarding future net earnings per share, measuring the growth rate of profitability. The upward trend of this indicator confirms institutional confidence in the product's commercialization, although buying at peaks increases the risk of overpayment.

Competitor analysis for Nexalin Technology, Inc.

ACHC (acadiahealthcare.com) - Earnings growth forecast for next year|LifeStance Health (LFST) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year BrainsWay Limited (BWAY)